1f40: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: left|200px<br /> <applet load="1f40" size="450" color="white" frame="true" align="right" spinBox="true" caption="1f40" /> '''SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH... |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1f40.gif|left|200px]]<br /> | [[Image:1f40.gif|left|200px]]<br /><applet load="1f40" size="350" color="white" frame="true" align="right" spinBox="true" | ||
<applet load="1f40" size=" | |||
caption="1f40" /> | caption="1f40" /> | ||
'''SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH GPI-1046, A NEUROTROPHIC LIGAND'''<br /> | '''SOLUTION STRUCTURE OF FKBP12 COMPLEXED WITH GPI-1046, A NEUROTROPHIC LIGAND'''<br /> | ||
==Overview== | ==Overview== | ||
The structure of a recently reported neurotrophic ligand, 3-(3-pyridyl)-1-propyl(2S)-1-(3,3-dimethyl-1, 2-dioxopentyl)-2-pyrrolidinecarboxylate, in complex with FKBP12 was | The structure of a recently reported neurotrophic ligand, 3-(3-pyridyl)-1-propyl(2S)-1-(3,3-dimethyl-1, 2-dioxopentyl)-2-pyrrolidinecarboxylate, in complex with FKBP12 was determined using heteronuclear NMR spectroscopy. The inhibitor exhibits a binding mode analogous to that observed for the macrocycle FK506, used widely as an immunosuppressant, with the prolyl ring replacing the pipecolyl moiety and the amide bond in a trans conformation. However, fewer favourable protein-ligand interactions are detected in the structure of the complex, suggesting weaker binding compared with the immunosuppressant drug. Indeed, a micromolar dissociation constant was estimated from the NMR ligand titration profile, in contrast to the previously published nanomolar inhibition activity. Although the inhibitor possesses a remarkable structural simplicity with respect to FK506, 15N relaxation studies show that it induces similar effects on the protein dynamics, stabilizing the conformation of solvent-exposed residues which are important for mediating the interaction of immunophilin/ligand complexes with molecular targets and potentially for the transmission of the neurotrophic action of FKBP12 inhibitors. | ||
==About this Structure== | ==About this Structure== | ||
1F40 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with GPI as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http:// | 1F40 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=GPI:'>GPI</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1F40 OCA]. | ||
==Reference== | ==Reference== | ||
| Line 14: | Line 13: | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Cowley, D | [[Category: Cowley, D J.]] | ||
[[Category: Guenet, C.]] | [[Category: Guenet, C.]] | ||
[[Category: Improta, S.]] | [[Category: Improta, S.]] | ||
[[Category: Merly, J | [[Category: Merly, J P.]] | ||
[[Category: Saudek, V.]] | [[Category: Saudek, V.]] | ||
[[Category: Sich, C.]] | [[Category: Sich, C.]] | ||
| Line 24: | Line 23: | ||
[[Category: isomerase]] | [[Category: isomerase]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:34:33 2008'' | ||